EXAS EXACT Sciences Corporation

$69.68

*Only the 1D chart reflects 15-min delayed quotes during market hours. Other timeframes update after market close.

Reporting for fiscal period ending —
Expected on —
Report Time: Unknown Release Time
The Whisper Number
—
Consensus Estimate: —
Revenue Estimate: —

Latest Earnings Insight

Exact Sciences (EXAS) is poised for its upcoming earnings release on November 3, 2025, with a market cap of approximately $11.88 billion, reflecting its solid position in the healthcare diagnostics sector. The company's anticipated revenue of $810.37 million underscores its steady growth trajectory, even as the EPS estimate stands at $0.00, aligning with the whisper number. This suggests that market expectations are tempered, possibly due to the company's strategic investments in expanding its product offerings and enhancing its technological capabilities. Investors will be keenly observing how these strategic decisions translate into financial performance, particularly in light of Exact Sciences' commitment to innovation in cancer diagnostics. As the company continues to navigate a competitive landscape, its ability to meet or exceed these expectations could significantly influence market sentiment and future valuation.

Updated On 11/18/2025

About EXACT Sciences Corporation

Exact Sciences Corporation offers cancer screening and diagnostic test products in the United States and internationally. The company is headquartered in Madison, Wisconsin.

Website: https://www.exactsciences.com

Sector
TRADE & SERVICES
Industry
SERVICES-COMMERCIAL PHYSICAL & BIOLOGICAL RESEARCH
Exchange
NASDAQ
Country
USA
Currency
USD
Fiscal Year End
December
CIK
1124140
Address
441 CHARMANY DRIVE, MADISON, WI, US
Valuation
Market Cap
$7.72B
P/E Ratio
nan
PEG Ratio
-1.07
Price to Book
3.21
Performance
EPS
$-5.59
Dividend Yield
—
Profit Margin
-37.30%
ROE
-37.10%
Technicals
50D MA
$46.56
200D MA
$55.78
52W High
$72.83
52W Low
$39.97
Fundamentals
Shares Outstanding
186M
Target Price
$66.89
Beta
1.14

EXAS EPS Estimates vs Actual

● Estimated
● Actual

EXAS News & Sentiment

Nov 17, 2025 • Zacks Commentary SOMEWHAT-BULLISH
Molina Secures Deal From AHCA to Serve Florida's Medicaid Members
MOH wins sole contract from AHCA to manage care for around 120,000 Florida enrollees of SMMC and CHIP through a Medicaid deal.
Nov 14, 2025 • Zacks Commentary NEUTRAL
TEM Continues to Strengthen Its Genomics Leadership With New Products
Tempus AI advances its genomics push with new assays, CDx progress and plans for whole-genome sequencing to drive future growth.
Nov 13, 2025 • Motley Fool SOMEWHAT-BULLISH
MDxHealth ( MDXH ) Q3 2025 Earnings Call Transcript
Image source: The Motley Fool.Wednesday, Nov. 12, 2025 at 4:30 p.m. ETNeed a quote from a Motley Fool analyst? Email pr@fool.comContinue reading ...
Nov 13, 2025 • Zacks Commentary SOMEWHAT-BULLISH
Ensign Group Shares Decline 2.2% Despite Q3 Earnings Beat
ENSG shares slip 2.2% despite Q3 earnings and revenues topping estimates, as higher service and rent costs weigh on results.
Nov 13, 2025 • Benzinga SOMEWHAT-BULLISH
Cathie Wood Dumps $30 Million Worth Of Tesla Stock Amid China Sales Slump, Loads Up Circle And This Hot Chinese AI Stock - Tesla ( NASDAQ:TSLA )
On Wednesday, Cathie Wood-led Ark Invest executed significant trades involving Circle Internet Group Inc. ( NYSE:CRCL ) , Alibaba Group Holding Ltd. ( NYSE:BABA ) , and Tesla Inc. ( NASDAQ:TSLA ) . These trades reflect Ark's strategic positioning in the market, with notable buys in Circle and ...
Nov 12, 2025 • Zacks Commentary NEUTRAL
RGTI Stock Down Despite Q3 Earnings Top Estimates, Revenues Decline Y/Y
Rigetti's Q3 loss is narrower than estimates, but revenues decline as government contract delays hit sales and lower the gross margin.
Sentiment Snapshot

Average Sentiment Score:

0.251
50 articles with scored sentiment

Overall Sentiment:

Bullish

EXAS Reported Earnings

Aug 06, 2025
Jun 30, 2025 (Pre market)
0.12 Surprise
  • Reported EPS: $-0.01
  • Estimate: $-0.13
  • Whisper: —
  • Surprise %: 92.3%
May 01, 2025
Mar 31, 2025 (Pre market)
0.11 Surprise
  • Reported EPS: $-0.36
  • Estimate: $-0.47
  • Whisper: —
  • Surprise %: 23.8%
Feb 19, 2025
Dec 31, 2024 (Pre market)
0.09 Surprise
  • Reported EPS: $-0.24
  • Estimate: $-0.33
  • Whisper: —
  • Surprise %: 27.7%
Nov 05, 2024
Sep 30, 2024 (Post market)
0.0 Surprise
  • Reported EPS: $-0.21
  • Estimate: $-0.21
  • Whisper: —
  • Surprise %: 0.0%
Jul 31, 2024
Jun 30, 2024 (Post market)
0.23 Surprise
  • Reported EPS: $-0.09
  • Estimate: $-0.32
  • Whisper: —
  • Surprise %: 71.9%
May 08, 2024
Mar 31, 2024 (Post market)
-0.13 Surprise
  • Reported EPS: $-0.60
  • Estimate: $-0.47
  • Whisper: —
  • Surprise %: -27.7%
Feb 21, 2024
Dec 31, 2023 (Post market)
0.19 Surprise
  • Reported EPS: $-0.27
  • Estimate: $-0.46
  • Whisper: —
  • Surprise %: 41.3%
Nov 01, 2023
Sep 30, 2023 (Post market)
0.48 Surprise
  • Reported EPS: $0.00
  • Estimate: $-0.48
  • Whisper: —
  • Surprise %: 100.9%
Aug 01, 2023
Jun 30, 2023 (Post market)
0.06 Surprise
  • Reported EPS: $-0.45
  • Estimate: $-0.51
  • Whisper: —
  • Surprise %: 11.8%

Financials